HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of Ureaplasma infection pattern and azithromycin treatment effect with bronchopulmonary dysplasia in Ureaplasma positive infants: a cohort study.

AbstractBACKGROUND:
It is unclear whether Ureaplasma-associated pneumonia and azithromycin treatment affect the risk for bronchopulmonary dysplasia (BPD).
METHODS:
A retrospective cohort study was performed in very low birth weight (VLBW) infants who tested positive for Ureaplasma within 72 h after birth in a tertiary unit. Chest X-ray (CXR) and laboratory test were performed before and after azithromycin treatment. Multivariate logistic regression analysis was used to identify the independent association between BPD and Ureaplasma-associated pneumonia, as well as BPD and effective azithromycin treatment.
RESULTS:
A total of 118 infants were included in the current study, of whom 36 developed BPD (defined as supplemental oxygen needed at postmenstrual age 36 weeks or discharge). The rate of BPD was significantly higher in infants with Ureaplasma-associated pneumonia (44.6%) compared to infants with Ureaplasma colonization (17.7%, P = 0.002). After adjusting for confounders, an effective azithromycin treatment was significantly associated with reduced risk of BPD [odd ratio (OR) 0.011; 95% confidence interval (CI): 0.000-0.250), whereas Ureaplasma-associated pneumonia was not significantly associated with BPD (OR 1.835; 95% CI: 0.548-6.147).
CONCLUSION:
Effective Azithromycin treatment in Ureaplasma positive VLBW infants was associated with a reduced risk of BPD.
AuthorsXueyu Chen, Xuemei Huang, Yanqing Lin, Bingchun Lin, Chunyu Yang, Zhifeng Huang, Chuanzhong Yang
JournalBMC pulmonary medicine (BMC Pulm Med) Vol. 23 Issue 1 Pg. 229 (Jun 26 2023) ISSN: 1471-2466 [Electronic] England
PMID37365524 (Publication Type: Journal Article)
Copyright© 2023. The Author(s).
Chemical References
  • Azithromycin
Topics
  • Infant, Newborn
  • Humans
  • Infant
  • Azithromycin (therapeutic use)
  • Bronchopulmonary Dysplasia (epidemiology)
  • Infant, Premature
  • Ureaplasma
  • Cohort Studies
  • Retrospective Studies
  • Ureaplasma Infections (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: